WeChat Mini Program
Old Version Features

OA01.06 Randomised Phase 2 Study of Nivolumab (N) Versus Nivolumab and Ipilimumab (NI) Combination in EGFR Mutant NSCLC

G. Lai,J. Alvarez,J.C. Yeo,N.L. Sim,A. Tan,S. Zhou,L. Suteja,T.W. Lim,N. Rohatgi,J. Yeong,A. Takano,K.H.T. Lim,A. Gogna,C.W. Too,K.D. Zhuang,A. Jain,W. Tan,R. Kanesvaran, Q.S. Ng,M. Ang

Journal of Thoracic Oncology（2021）

Cited 6|Views29
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined